RSS

The University of Texas

Late clinical-stage nanomedicine company, Nanobiotix, has announced its cooperation with the University of Texas MD Anderson Cancer Center to run immunotherapeutic pre-clinical research combining NBTXR3 — the company’s lead product — with Nivolumab. more

News

A capsule has been developed that can treat people affected by the hereditary bleeding disorder haemophilia. more

News

Pharma companies have been teaming up in the fight against cancer. EPM lists the top 5 cancer fighting collaborations more

Opinion

Kymab and MD Anderson Cancer Centre have announced a strategic cancer drug discovery and development alliance more

News